Rights and permissions
About this article
Cite this article
… reductions in measles morbidity and mortality may not be the only benefit but tailored strategies should be adopted. Inpharma Wkly. 767, 4 (1990). https://doi.org/10.2165/00128413-199007670-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199007670-00007